Please login to the form below

Not currently logged in
Email:
Password:

acquisitions

This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead revenues and earnings have slipped in the second quarter, a decline which the company has attributed to disruption caused by the COVID-19 pandemic and costs associated with acquisition deals. ... Gilead also noted net loss for the second quarter

Latest news

More from news
Approximately 198 fully matching, plus 1,202 partially matching documents found.

Latest Intelligence

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Parikh has good reason to celebrate, as he has been involved in constructing a potent GI unit that took its first steps with Takeda’s 2008 acquisition of US biotechnology company ... We are completely focused on helping them.”. The GI building

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    Many with promising and potentially high-value platforms may be at risk of acquisition from larger companies based on unfavourable terms. ... Acquisitions might present the opportunity for larger companies to expand their pipelines with additional assets

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    traditional pharmaceutical companies look to increase innovation is through bolt-on acquisitions of more innovative players in the industry. ... But such bolt-on acquisitions are not just beneficial to Big Pharma – they can also benefit smaller firms.

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    That new strategy was thrown into relief by Sanofi’s acquisition of cancer specialist Synthorx, announced in December 2019 and completed in January 2020, the first major deal under Hudson’s

  • Novo Nordisk awakens its ‘Sleeping Beauty’ Novo Nordisk awakens its ‘Sleeping Beauty’

    The next phases were to enrich the pipeline with acquisitions and partnerships, including a headline deal with blue-bird bio for next generation gene editing that could lead to a potential ... The big thing I’ve started working on with the science and

More from intelligence
Approximately 74 fully matching, plus 88 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 79 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics